Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Explore which bond type—Treasury or corporate—typically incurs lower taxes in retirement and how that shapes your income strategy.
28,027 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Strategy, the software firm formerly known as MicroStrategy, reported a $12.77 billion first-quarter loss as Bitcoin ...
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Berkshire Hathaway just resumed stock buybacks after a long pause, signaling a shift in capital allocation. This arti...
Alphabet’s latest AI and cloud initiatives are fueling optimism, even as investors weigh whether Wall Street is under...
CrossCountry Mortgage appoints Raena Pinchuk as sales manager for Coeur d’Alene and the broader Pacific Northwest, ai...
Visa now dominates crypto-card payments, handling the vast majority of activity as stablecoins aimed to bypass legacy...
A consortium led by Barry Diller has proposed a $12.4 billion bid to take MGM Resorts private, a move that could resh...
WPP’s top creative executive warns that human creativity under fire as AI tools accelerate outputs and squeeze budget...
The iShares Semiconductor ETF faces a pivotal year as AI-capex decisions by five hyperscalers set the pace. SOXX’s ne...
Markets surge as investors debate mega-valuations tied to founder-led tech giants. This piece breaks down what everyd...
A stock that rockets higher in a year can attract curious investors. This article breaks down the fuel behind the sur...